Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -91.74% is 14% above its 5-year average of -106.08%, near the high end of its 5-year range (-261.17%–-24.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.46% above its 12-month average of -102.45%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -91.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-91.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-102.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-128.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-106.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.46%
CURRENT VS 3Y AVG
+28.34%
CURRENT VS 5Y AVG
+13.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 614 covered companies
CURRENT VS SECTOR MEDIAN
-174.79%
vs the sector median at left
IN8bio, Inc.
Market Cap
$13.62M
Return on Invested Capital (ROIC)
-91.74%
TTM Avg
-102.45%
3Y Avg
-128.02%
5Y Avg
-106.08%
Market Cap
$13.72M
Return on Invested Capital (ROIC)
-57.53%
TTM Avg
-660.45%
3Y Avg
-553.22%
5Y Avg
-396.73%
Market Cap
$13.25M
Return on Invested Capital (ROIC)
-28.72%
TTM Avg
-40.11%
3Y Avg
-38.90%
5Y Avg
-32.17%
Market Cap
$14.01M
Return on Invested Capital (ROIC)
-67.62%
TTM Avg
-48.11%
3Y Avg
-41.05%
5Y Avg
-37.60%
Market Cap
$13.10M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-42.56%
3Y Avg
-55.36%
5Y Avg
-44.03%
Market Cap
$12.86M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
Market Cap
$14.39M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.56M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-183.21%
3Y Avg
-122.71%
5Y Avg
-100.21%
Market Cap
$12.44M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IN8bio, Inc. (INAB) | $13.62M | -91.74% | -102.45% | -128.02% | -106.08% |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | -57.53% | -660.45% | -553.22% | -396.73% |
| Optimi Health Corp. (OPTH)vs › | $13.25M | -28.72% | -40.11% | -38.90% | -32.17% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.01M | -67.62% | -48.11% | -41.05% | -37.60% |
| Cytosorbents Corporation (CTSO)vs › | $13.10M | -43.31% | -42.56% | -55.36% | -44.03% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | -74.94% | -273.26% | -277.38% | -186.51% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.39M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.56M | N/A | -183.21% | -122.71% | -100.21% |
| Dare Bioscience, Inc. (DARE)vs › | $12.44M | -203.50% | -154.20% | -205.70% | -169.89% |
| IRIDEX Corporation (IRIX)vs › | $12.17M | -19.53% | -16.13% | -40.26% | -33.39% |
ROIC
-91.7%
ROE
-101.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -91.74% |
| 2026-03-31 | -79.46% |
| 2025-12-31 | -66.76% |
| 2025-09-30 | -137.13% |
| 2025-06-30 | -137.16% |
| 2025-03-31 | -162.16% |
| 2024-12-31 | -170.41% |
| 2024-09-30 | -261.17% |
| 2024-06-30 | -182.04% |
| 2024-03-31 | -144.55% |
| 2023-12-31 | -107.14% |
| 2023-09-30 | -140.35% |
| 2023-06-30 | -117.35% |
| 2023-03-31 | -142.86% |
| 2022-12-31 | -104.79% |
| 2022-09-30 | -79.36% |
| 2022-06-30 | -80.54% |
| 2022-03-31 | -53.48% |
| 2021-12-31 | -36.66% |
| 2021-09-30 | -24.71% |
| 2021-06-30 | -62.85% |
| 2021-03-31 | -52.63% |
| 2020-12-31 | -46.22% |
| 2020-06-30 | -395.59% |
| 2019-12-31 | -1048.86% |
